Skip to content
Balchem logo

Balchem

BCPC

Balchem Corporation is a global specialty chemicals company that develops, manufactures, and distributes high-performance ingredients for the nutritional, food, pharmaceutical, animal health, and industrial markets.

Market cap
$5.29B+6.7%
Revenue$1.1B+9.6%
Net income$158.1M+15.8%
EPS (diluted)$4.87+16.8%
Trailing twelve months · change vs. prior year

Earnings

Next report

Jul 31, 2026 (In 2 days)
Revenue estimate$268.5M
EPS estimate$1.27

Financials

Q1 2026

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation & ratios

Valuation

See full
Market cap$5.29B+6.7%
Enterprise value$5.26B+7.6%
P/E33.5×-0.9×
P/S0.0×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0.0×
Current ratio2.5×+0.1×

Segments

By segment

See full
Human Nutrition and Health$171.6M+8.3%
Animal Nutrition and Health$62.2M+8.6%
Specialty Products$34.7M+4.4%

Competitors

Profile

Balchem Corporation is a global specialty chemicals company that develops, manufactures, and distributes high-performance ingredients for the nutritional, food, pharmaceutical, animal health, and industrial markets. The company leverages proprietary microencapsulation and chelation technologies to deliver essential nutrients and performance gases that improve health, productivity, and product stability. Its core value proposition centers on scientific differentiation and technical expertise in human and animal nutrition as well as specialized sterilization solutions.

Competitive position

A leading provider of microencapsulation and chelation technologies with a strong intellectual property portfolio and significant capital investment in specialized gas distribution infrastructure.

GeographiesUnited States, Europe, Global
Customer segmentsFood and Beverage, Healthcare, Agribusiness, Animal Feed
Business modelManufacturing, B2B Distribution, Intellectual Property Licensing
SuppliersPetrochemical suppliers, Mineral and metal suppliers, Agricultural commodity providers, Packaging material manufacturers
CustomersFood and beverage manufacturers, Medical device companies, Livestock producers, Commercial farmers, Hospitals
Listed1986
Employees1.3K
CEOTheodore L. Harris
FilingsSEC EDGAR

Questions, answered.

What is Balchem's market cap?
Balchem (BCPC) has a market capitalization of $5.3B and trades on NASDAQ.
What is Balchem's revenue and profitability?
Balchem generated $1.1B in trailing twelve-month revenue with net income of $158.1M, representing a net margin of 15.0%. Gross margin stands at 36.3%. These figures are based on the Q1 2026 filing.
Who are Balchem's competitors?
Balchem's key competitors include Archer-Daniels-Midland Company, Future Fuel Corporation, Phibro Animal Health Corporation Class A, and others. These companies compete in similar markets and product categories.
What subsidiaries does Balchem have?
Balchem's subsidiaries include Balchem Italia Srl, BCP Ingredients, Inc..
Where is Balchem headquartered?
Balchem is headquartered in United States of America and employs approximately 1,301 people. It has been publicly traded since 1986.